Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Pediatric Hematology
How would you approach management of bleeding risk and factor VIII replacement in a patient with severe hemophilia A undergoing stem cell transplant?
Answer from: at Academic Institution
Same way as anyone with severe hemophilia: Prophy with QOD factor or weekly hemlibra Extra correction for procedures, trauma, or bleeding
Comments
at Ann & Robert H. Lurie Children’s Hospital of Chicago
Thank you Dr. @Gary Kupfer! Would you have any con...
at Georgetown University Hospital
Good point. I wouldn’t say it is studied...
7770
7773
Sign in or Register to read more
15541
Related Questions
In an adult patient with asymptomatic, isolated neutropenia in whom you suspect a Duffy null phenotype, at what ANC or in what situations would you do a bone marrow to look for other etiologies of neutropenia?
What is your recommended long term management of extensive dural venous sinus thrombosis in an otherwise healthy young patient?
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
What experience have you had with familial clustering of polycythemia vera?
What is your criteria for considering oral, or IV, iron repletion in pediatric patients referred to Hematology for restless leg syndrome?
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
What is your approach to an infant (<12 mo) with new onset petechiae and thrombocytopenia, with labs consistent with ITP?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
Thank you Dr. @Gary Kupfer! Would you have any con...
Good point. I wouldn’t say it is studied...